C.M. Bidwell & Associates’s CareDx CDNA Stock Holding History

C.M. Bidwell & Associates’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27	Closed	-$479	–	460
2025 Q1	$479	Buy	27 +12	+80%	+$258	﹤0.01%	419
2024 Q4	$321	Hold	15	–	–	﹤0.01%	475
2024 Q3	$468	Buy	+15	New	+$373	﹤0.01%	467
2021 Q4	–	Sell	-185	Closed	-$12K	–	557
2021 Q3	$12K	Hold	185	–	–	0.01%	376
2021 Q2	$17K	Hold	185	–	–	0.01%	360
2021 Q1	$13K	Hold	185	–	–	0.01%	373
2020 Q4	$13K	Buy	+185	New	+$10.7K	0.01%	357

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

C.M. Bidwell & Associates's CDNA Position: Q2 2025 in Review

C.M. Bidwell & Associates sold out of CareDx (CDNA) in Q2 2025, closing a stake of 27 shares — an estimated $479 sold.

C.M. Bidwell & Associates first reported a position in CDNA in Q4 2020 and held it in 7 quarters. The position peaked at $17K in Q2 2021. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

C.M. Bidwell & Associates reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
C.M. Bidwell & Associates sold 27 CareDx shares in Q2 2025, an estimated $479.
C.M. Bidwell & Associates first reported a position in CareDx in Q4 2020 and held it in 7 quarters.
C.M. Bidwell & Associates's CareDx position peaked at $17K in Q2 2021.
197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2025, filed 14 Aug 2025.